Background {#Sec1}
==========

Human rhinovirus (HRV) is the most prevalent viral respiratory pathogen in humans and the predominant aetiology of the "common cold". It has also been associated with influenza-like illness \[[@CR1]\], otitis media \[[@CR2]\] and exacerbations of asthma and chronic obstructive pulmonary disease \[[@CR3], [@CR4]\]. HRV infections, thus, represent a significant global health burden, as well as substantial cost for health care and lost productivity \[[@CR5]\].

HRV belongs to the *Enterovirus* genus, family Picornaviridae, and is genetically diverse. A multitude of serotypes and genotypes (currently around 150) have been described, hereafter referred to as types. Previously being classified into two species, HRV-A and HRV-B, sequencing-based studies revealed a third species in 2006, HRV-C, which circulates worldwide \[[@CR6]--[@CR10]\]. HRV-C was initially reported to cause more severe symptoms than HRV-A and HRV-B, but further studies have reported similar clinical presentation across HRV species \[[@CR9]\].

In temperate regions, acute respiratory tract infection (ARTI) of viral aetiology typically appear as temporally restricted epidemics during the winter season \[[@CR11]\]. In particular, influenza A and respiratory syncytial virus (RSV) infections cause distinct epidemics lasting 1--2 months. In contrast, infections caused by HRVs appear throughout the entire year, sometimes with peaks in early autumn and spring \[[@CR12]--[@CR15]\]. The overall high incidence and observed lower degree of seasonality for HRV could reflect that there are several parallel or successive epidemics with different HRV types, each appearing in a time-limited fashion, similar to what is observed for other viruses causing ARTIs. A multitude of HRV types during each season has been observed earlier, both a long time ago by surveillance studies using viral culture \[[@CR16]\] and more recently by molecular epidemiology investigations \[[@CR17]--[@CR20]\].

The aim of the study was to identify HRV types circulating in one geographic area across several seasons and to compare the strains detected in this area with published HRV sequences retrieved from other parts of the world.

Methods {#Sec2}
=======

Samples {#Sec3}
-------

During the period from November 2006 through September 2010, 11,498 respiratory samples were sent to the Virological Laboratory at the Sahlgrenska University Hospital for the diagnosis of ARTI by a multiple real-time polymerase chain reaction (PCR) panel. HRV was detected in 16 % of all the samples and in 25 % of samples from children below 5 years of age. The samples were sent from various health care units within a catchment area of approximately 500,000 inhabitants in the city of Gothenburg on the west coast of Sweden. In the present study, 170 samples positive for HRV (9 % of the total number of samples positive for HRV) were selected for typing by sequencing of the VP4/VP2 region. The samples were selected so as to represent the autumn as well as the spring seasons each year.

Real-time PCR {#Sec4}
-------------

The multiple real-time PCR assay, which targets 15 respiratory agents, has been described previously \[[@CR21]\]. One of the reaction wells contains oligonucleotides targeting rhinovirus, *Mycoplasma pneumoniae* and coronavirus 229E. Conserved parts of the rhinovirus genome are targeted with a mixture of three forward primers (GGTGTGAAGAGCCSCRTGTGCT, GGTGTGAAGACTCGCATGTGCT, GGGTGYGAAGAGYCTANTGTGCT), one reverse primer (GGACACCCAAAGTAGTYGGTYC) and one minor groove binding probe (TCCGGCCCCTGAATG).

Sequencing of the VP4/VP2 region and phylogeny {#Sec5}
----------------------------------------------

After total nucleic acid extraction in a MagNA Pure LC instrument (Roche, Branchburg, NJ, USA), amplification was performed using the primers Rhino_547F, ACCRACTACTTTGGGTGTCCGTG and Rhino_1125R, ACATRTTTTSiCCAAAiAiiCCCAT in a first PCR and Rhino_547F and Rhino_1087R, TCWGGiARYTTCCAMCACCAiCC in a second PCR (i = inosine). Cycle sequencing was carried out in both directions using ABI BigDye Terminators (Life Technologies, Carlsbad, CA, USA) and Rhino_547F and Rhino_1087R as primers, and the sequences were read in an ABI 3130XL instrument and assembled using the Lasergene software (DNASTAR, Inc., Madison, WI, USA). VP4/VP2 sequences in this study have been assigned EMBL accession numbers HE993758--HE993869.

Analysis strategy {#Sec6}
-----------------

The obtained sequences from local samples were compared with reference sequences from other geographical areas representing known HRV types. These references included 74 HRV-A, 24 HRV-B and 50 HRV-C sequences, classified as suggested by the International Committee on Taxonomy of Viruses (ICTV) Picornaviridae Study Group, [http://www.picornastudygroup.com](http://www.picornastudygroup.com/) (with provisional classification for 14 HRV-C sequences). In order to retrieve the 5--10 published sequences of the same type with the closest similarity, a BLAST search was also performed for each of our sequences. These sequences were then used for detailed phylogenetic analysis of the types that were found in our population during several seasons.

Phylogeny and classification {#Sec7}
----------------------------

A segment of 395 nucleotides (nt) from the analysed strains were aligned along with reference sequences, and phylogenetic trees were constructed by maximum-likelihood analysis using the MEGA5 software \[[@CR22]\], applying pairwise deletion for missing data and the Tamura--Nei model for nucleotide substitutions. Type assignment of our sequences was based on \>90 % nt similarity to a reference sequence or clustering with a reference sequence in phylogenetic analysis with a bootstrap value above 70.

Genetic distances between and within HRV-A, HRV-B and HRV-C were compared by Student's *t*-test.

Results {#Sec8}
=======

HRV types {#Sec9}
---------

In all, 114/170 samples produced amplicons and sequences of sufficient length and quality for phylogenetic comparison. By VP4/VP2 sequence analysis, we found HRV-A in 64, HRV-B in 11 and HRV-C in 37 cases. In two cases that were reactive for both HRV and enterovirus in real-time PCR, coxsackie virus A9 and enterovirus 68 were detected. There were 33 different HRV-A types, nine different B types and 21 different C types. As shown in Table [1](#Tab1){ref-type="table"}, the most commonly detected types were C9 (*n* = 7) and A56 (*n* = 5).Table 1Human rhinovirus (HRV) types identified during four seasonsHRV typeTotal06/0707/0808/0909/10A722A10321A12321A1311A2022A2811A3011A33312A34312A3622A3911A4111A43211A4611A4722A49321A5333A5522A56523A58211A59211A60211A63211A6511A6611A6722A6822A7111A7511A77211A783111A8011A8211B622B2611B4211B7011B7211B8411B91211B9211B9711C?11C7?211C8?11C97241C1111C12211C14211C1522C1611C1811C2211C2411C2522C2611C29?11C3522C38211C3911C4333C4422C46?11HRV-C sequences with \>15 % divergence from reference sequences are indicated by a question markThe 09/10 season includes four cases from September 2010

Forty-seven percent (54/114) of the samples were obtained from children (age \<18 years) and 49 % (56/114) were from females. The distribution in terms of month of sampling, age of patients and HRV types is shown in Fig. [1](#Fig1){ref-type="fig"}. The age ranged from 2 weeks to 90 years: 27 % were \<12 months, 24 % were 1.0--9.9 years and 49 % were 10.0--90 years of age. In patients aged 10 years or more, HRV-B was relatively more common (17 %) and HRV-C was relatively less common (24 %) than in those younger than 10 years of age (3.5 % and 42 %, respectively). In samples taken in September, there was a predominance of HRV-A and HRV-B in samples from patients who were more than 10 years old.Fig. 1Distribution of patient age, virus type and sample collection time point for 112 human rhinovirus (HRV) infections

Seasonal distribution of types {#Sec10}
------------------------------

Each season, defined as September through May in the following year, several HRV types were observed. In 2006/2007, we found nine A types, one B type and two C types; in 2007/2008, we found 12 A types, three B types and seven C types; in 2008/2009, we found 29 A types, two B types and 17 C types; in 2009/2010, we found 12 A types, three B types and 12 C types. Some types were found across several seasons, such as A78 and C9, which appeared during three consecutive seasons, and A10, A12, A33, A34, A43, A49, A56, A58, A59, A60, A63, A77, A78, B91, C7, C12, C14, C35 and C38, which appeared during two seasons.

Phylogenetic analysis of nucleotide sequences {#Sec11}
---------------------------------------------

The mean nucleotide difference was 39.3 % between HRV-A and HRV-B, 38.5 % between HRV-A and HRV-C, and 40.2 % between HRV-B and HRV-C. The variability within HRV-C strains was greater (24.4 %) than within HRV-A (20.3 %, *p* \< 0.0001) and HRV-B (21.1 %, *p* = 0.0002) strains.

The phylogenetic tree in Fig. [2](#Fig2){ref-type="fig"} shows all the HRV sequences identified in our investigation, along with reference sequences representing the various HRV types that were observed. The tree reveals that some of the HRV types appeared during two or three seasons, suggesting that these types might circulate in the population over long time periods. To further explore this, we constructed phylogenetic trees for each of these types, including sequences from our patients in comparison with ≈10 related sequences from GenBank retrieved by BLAST search. As shown in Fig. [3](#Fig3){ref-type="fig"}, some of these trees, indeed, show examples of strains or lineages of HRV that circulated in our population for 5--12 months, as indicated by a greater genetic similarity between them than with the most closely related sequences in GenBank. This analysis indicated that an HRV-A10 strain remained for 4 months, A33 for 12 months, A34 for 5 months, A49 for 4 months, A56 for 2 months, A60 for 7 months, C9 for 9 months, C14 for 10 months and C43 for 3 months. In other cases (Fig. [3](#Fig3){ref-type="fig"}b, e, j), strains belonging to the same type were more similar to database sequences than to each other. These trees also demonstrate that, for most of the HRV strains from our patients, there were several closely related sequences found in GenBank. The majority of the related sequences had been collected during the same year as our sequence, or the previous or following years.Fig. 2Phylogenetic tree by maximum-likelihood analysis of 112 HRV sequences from the present study and database reference sequences (*in bold*). The coloured dots indicate the sampling season: *pink*, 2006/2007; *red*, 2007/2008; *blue*, 2008/2009; *green*, 2009/2010; *black* 2010 Fig. 3Phylogenetic tree by maximum-likelihood analysis of HRV types appearing for two or more seasons. For trees that support persistence of strains, the duration of this persistence is given in *parentheses*. The bootstrap values indicate how frequently the tree topology appeared when 1000 replicate trees were analysed. The coloured dots indicate the season: *pink*, 2006/2007; *red*, 2007/2008; *blue*, 2008/2009; *green*, 2009/2010; *black* 2010

Putative new types {#Sec12}
------------------

One HRV-B (DE8-2793) and six HRV-C sequences (DE9-2878, DE10-2553, DE7-5952, DE9-9782, DE9-2601 and DE8-2155) showed less than 85 % nucleotide similarity with the most similar reference sequences (B6, C7, C8, C29 and C46), suggesting that they might represent new types. For each of these cases, there was at least one published sequence with 91--98 % similarity (in VP4/VP2), but the HRV types of these published sequences has not been defined because the strains have not been analysed in VP1, which is required for type assignment \[[@CR23]\].

Discussion {#Sec13}
==========

In contrast to infections with most other enveloped respiratory viruses, such as influenza virus or RSV, HRV infections are common across all seasons, with a slightly lower incidence during summer and a peak in early autumn. To some extent, the seasonal pattern of HRV infections prevailing throughout the year might be explained by the great genetic diversity between and within HRV types. Thus, each HRV type might cause a restricted outbreak similar to most other viral ARTI agents. If this was true, HRV types would circulate in the local population during a limited time span, and over a four-year period, one would, by sequencing studies, be able to observe a large number of successive epidemics caused by different HRV types. It might be anticipated that a very large number of HRV strains would have to be sequenced in order to clarify this issue properly. Still, despite the limited sample size, this possibility was, to some extent, supported by the present study. Firstly, many HRV types were observed during each season and different types appeared over time. Secondly, the application of a BLAST search strategy on each HRV type that re-appeared during several seasons made it possible to show that such cases were sometimes caused by different strains of the same HRV type, with each strain closely related to strains observed in other parts of the world at approximately the same time. For example, two cases of HRV-A12 presenting in March 2008 were unrelated to another HRV-A12 strain found in April 2010, and one HRV-A10 strain appearing in May 2009 was more similar to strains from Italy, USA, Japan and Switzerland than to another HRV-A10 strain found in one of our samples from the same month. These findings support that HRV strains may appear locally in a time-limited fashion, similarly to outbreak patterns typical for influenza A and RSV \[[@CR11]\].

However, other HRV strains appeared to circulate in our population over relatively long time periods, in some cases from spring to autumn. For example, one HRV-C9 appearing in November 2009 was identical to other C9 strains from March 2009, and an HRV-A33 sequence from September 2008 was identical to another one found one year earlier. These cases demonstrate that HRV epidemics may be more long lasting than influenza A and RSV outbreaks, which typically wane after 4--8 weeks, when the number of susceptible individuals have declined below a critical level. The explanation to the more extended duration of HRV epidemics is probably multi-factorial. Firstly, the clinical presentation of HRV infections is, overall, milder compared with influenza A, and HRV have been identified in significant proportions of individuals without ongoing respiratory symptoms \[[@CR15], [@CR24], [@CR25]\]. Thus, HRV-infected subjects are more likely to expose other people to the infection. Secondly, HRV are shed during longer time periods, typically 2--3 weeks, as compared with less than 1 week for influenza A \[[@CR26]\], probably resulting in a higher likelihood of spreading of the infection. Immunocompetent individuals may even shed the same strain of HRV for more than 4 weeks \[[@CR27]--[@CR29]\], and in immunocompromised individuals, shedding for as long as 27 months has been observed \[[@CR30]\]. Thirdly, the robust unenveloped virion structure of HRV may increase the likelihood of indirect transmission via surfaces \[[@CR30]\].

Our study differs from most previous reports by having a longer observation period and by not being performed in a defined patient group, such as hospitalized children, but representing a judgement sample of rhinoviruses in different types of patients seeking medical care during a defined time period in a fairly well-defined area. Still, the observed proportions of HRV types (57 % HRV-A, 10 % HRV-B and 33 % HRV-C) largely agrees with recent reports from UK, Italy, France and Japan (47--62 % HRV-A, 6--9 % HRV-B and 30--47 % HRV-C \[[@CR17], [@CR19], [@CR20], [@CR31]\]. The total number of observed types in the present study (33 HRV-A, nine HRV-B and 21 HRV-C types) was higher than the 22 HRV-A, six HRV-B and 15 HRV-C types that were reported by Wisdom et al. over a period of 6 months but less than the 71 HRV-A, ten HRV-B and 47 HRV-C reported over 26 months by Tapparel et al. \[[@CR32]\].

In the present study, phylogeny based on VP4/VP2 sequences was used for classification. This has previously been shown to agree well with the more reliable typing by phylogeny of VP1 sequences, and for HRV-A and HRV-B, a good correlation has been documented for VP1 sequence phylogeny and serological classification \[[@CR18], [@CR33], [@CR34]\]. For HRV-C, in the absence of serological typing techniques, the classification of HRV is based solely on sequence comparison, and a nucleotide divergence of more than 13 % in VP1 has been proposed to be used to define new HRV-C types \[[@CR23]\]. The VP4/VP2 region can also be used to classify HRV-C, but it is not considered to be sufficient for the identification of new types \[[@CR23]\]. Thus, additional sequencing of VP1 is required in order to clarify if any of the five HRV-C sequences (and one HRV-B sequence) that were more than 15 % different in the VP4/VP2 region might represent a new HRV type.

Our multiple PCR contains separate reaction mixtures for HRV and enterovirus, in order to allow distinction between these agents. Despite this, enteroviruses were found in two cases that were positive by the HRV real-time PCR. This reactivity is explained by the genetic similarity between HRV and enterovirus, but these cases were reactive with lower Ct values by the enterovirus component of the real-time PCR panel. The observation that enteroviruses may cause ARTI and be detected in nasal swabs is well known, and the relative frequency of enterovirus infections found in our study is similar to what others have reported \[[@CR18]\].

In summary, we observed a wide spectrum of HRV types, changing over time, which may contribute to the seasonal pattern of HRV infections throughout the year. HRV in our patients were often closely related to published sequences from distant locations, suggesting that HRV epidemics may be highly globalised. However, some of the results demonstrated the presence of the same HRV types across extended time periods, which calls for further studies on the impact of the duration of viral shedding, virion structure robustness and insufficient immune responses in order to explain why HRV is the most common ARTI agent worldwide.
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